2026 PANP360 Immersive Philadelphia

At the completion of this activity, participants should be better able to:
Categorize the pathology and mechanism of action of therapies for atopic dermatitis, psoriasis and hidradenitis suppurativa.
Compare therapeutic options for inflammatory conditions like atopic dermatitis, psoriasis and hidradenitis suppurativa.
Apply varying diagnostic tools to alopecia case examples.
Discuss clinical data regarding the role of glucagon-like peptide-1 (GLP-1) receptor agonists in psoriasis with the aim to troubleshoot utilization challenges and provide patient education.
Recognize the clinical presentation and how to optimize treatment for patients with hidradenitis suppurativa, psoriasis and atopic dermatitis.
Appraise and implement evidence-based management strategies for common dermatologic conditions through case-based discussions, hands-on practice, and collaborative problem-solving.